{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:25:18Z","timestamp":1789457118419,"version":"build-2803163510"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"crossref","award":["MTA-PPD 462025"],"award-info":[{"award-number":["MTA-PPD 462025"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"crossref"}]},{"name":"New National Excellence Program of the Ministry for Culture and Innovation","award":["\u00daNKP-23-3-II-SE-17"],"award-info":[{"award-number":["\u00daNKP-23-3-II-SE-17"]}]},{"name":"New National Excellence Program of the Ministry for Culture and Innovation","award":["\u00daNKP-23-5-CORVINUS-5"],"award-info":[{"award-number":["\u00daNKP-23-5-CORVINUS-5"]}]},{"name":"J\u00e1nos Bolyai Research Scholarship of the Hungarian Academy of Sciences","award":["BO\/00304\/21"],"award-info":[{"award-number":["BO\/00304\/21"]}]},{"DOI":"10.13039\/100018253","name":"Corvinus University of Budapest","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018253","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40273-024-01360-4","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T11:02:08Z","timestamp":1709118128000},"page":"583-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3170-728X","authenticated-orcid":false,"given":"Anna","family":"Nikl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-6949","authenticated-orcid":false,"given":"Mathieu F.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-2514","authenticated-orcid":false,"given":"Bal\u00e1zs","family":"Jenei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6095-2295","authenticated-orcid":false,"given":"Valentin","family":"Brodszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-620X","authenticated-orcid":false,"given":"Fanni","family":"Rencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"issue":"Suppl 1","key":"1360_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40273-017-0545-x","volume":"35","author":"J Brazier","year":"2017","unstructured":"Brazier J, Ara R, Rowen D, Chevrou-Severac H. A review of generic preference-based measures for use in cost-effectiveness models. Pharmacoeconomics. 2017;35(Suppl 1):21\u201331. https:\/\/doi.org\/10.1007\/s40273-017-0545-x.","journal-title":"Pharmacoeconomics"},{"key":"1360_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-47622-9","volume-title":"Methods for analysing and reporting EQ-5D data","author":"N Devlin","year":"2020","unstructured":"Devlin N, Parkin D, Janssen B. Methods for analysing and reporting EQ-5D data. Cham (CH): Springer; 2020."},{"key":"1360_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldq033","volume":"96","author":"SJ Whitehead","year":"2010","unstructured":"Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5\u201321. https:\/\/doi.org\/10.1093\/bmb\/ldq033.","journal-title":"Br Med Bull"},{"issue":"3","key":"1360_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/0272989x14543107","volume":"35","author":"J Richardson","year":"2015","unstructured":"Richardson J, Khan MA, Iezzi A, Maxwell A. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments. Med Decis Making. 2015;35(3):276\u201391. https:\/\/doi.org\/10.1177\/0272989x14543107.","journal-title":"Med Decis Making"},{"issue":"8","key":"1360_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","volume":"21","author":"M Kennedy-Martin","year":"2020","unstructured":"Kennedy-Martin M, Slaap B, Herdman M, van Reenen M, Kennedy-Martin T, Greiner W, et al. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur J Health Econ. 2020;21(8):1245\u201357. https:\/\/doi.org\/10.1007\/s10198-020-01195-8.","journal-title":"Eur J Health Econ"},{"issue":"11","key":"1360_CR6","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s11136-016-1375-6","volume":"25","author":"F Rencz","year":"2016","unstructured":"Rencz F, Gul\u00e1csi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, et al. EQ-5D in Central and Eastern Europe: 2000\u20132015. Qual Life Res. 2016;25(11):2693\u2013710. https:\/\/doi.org\/10.1007\/s11136-016-1375-6.","journal-title":"Qual Life Res"},{"issue":"3","key":"1360_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9.","journal-title":"Health Policy"},{"issue":"10","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res"},{"issue":"6","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-018-0642-5","volume":"36","author":"I Buchholz","year":"2018","unstructured":"Buchholz I, Janssen MF, Kohlmann T, Feng YS. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645\u201361. https:\/\/doi.org\/10.1007\/s40273-018-0642-5.","journal-title":"Pharmacoeconomics"},{"key":"1360_CR10","unstructured":"Emberi Er\u0151forr\u00e1sok Miniszt\u00e9riuma. Az Emberi Er\u0151forr\u00e1sok Miniszt\u00e9riuma eg\u00e9szs\u00e9g\u00fcgyi szakmai ir\u00e1nyelve az eg\u00e9szs\u00e9g-gazdas\u00e1gtani elemz\u00e9sek k\u00e9sz\u00edt\u00e9s\u00e9hez \u00e9s \u00e9rt\u00e9kel\u00e9s\u00e9hez. Eg\u00e9szs\u00e9g\u00fcgyi K\u00f6zl\u00f6ny. 2021;71(21):2178\u2013200."},{"issue":"9","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40273-022-01159-1","volume":"40","author":"D Rowen","year":"2022","unstructured":"Rowen D, Mukuria C, McDool E. A systematic review of the methodologies and modelling approaches used to generate international EQ-5D-5L value sets. Pharmacoeconomics. 2022;40(9):863\u201382. https:\/\/doi.org\/10.1007\/s40273-022-01159-1.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"1360_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","volume":"30","author":"YS Feng","year":"2021","unstructured":"Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30(3):647\u201373. https:\/\/doi.org\/10.1007\/s11136-020-02688-y.","journal-title":"Qual Life Res"},{"issue":"6","key":"1360_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"2","key":"1360_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271\u201392. https:\/\/doi.org\/10.1016\/s0167-6296(01)00130-8.","journal-title":"J Health Econ"},{"issue":"1","key":"1360_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/13696998.2023.2195753","volume":"26","author":"L Wang","year":"2023","unstructured":"Wang L, Poder TG. A systematic review of SF-6D health state valuation studies. J Med Econ. 2023;26(1):584\u201393. https:\/\/doi.org\/10.1080\/13696998.2023.2195753.","journal-title":"J Med Econ"},{"issue":"9","key":"1360_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18090","volume":"18","author":"L Longworth","year":"2014","unstructured":"Longworth L, Yang Y, Young T, Mulhern B, Hern\u00e1ndez Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1\u2013224. https:\/\/doi.org\/10.3310\/hta18090.","journal-title":"Health Technol Assess"},{"key":"1360_CR17","doi-asserted-by":"publisher","unstructured":"Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):vii-viii, xiii-xxv, 1\u2013188. https:\/\/doi.org\/10.3310\/hta18340","DOI":"10.3310\/hta18340"},{"issue":"5","key":"1360_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737167.2023.2189590","volume":"23","author":"A Zhang","year":"2023","unstructured":"Zhang A, Mao Z, Wang Z, Wu J, Luo N, Wang P. Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review. Expert Rev Pharmacoecon Outcomes Res. 2023;23(5):449\u201368. https:\/\/doi.org\/10.1080\/14737167.2023.2189590.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"1360_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","volume":"22","author":"D Cella","year":"2019","unstructured":"Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, et al. PROMIS(\u00ae) adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019;22(5):537\u201344. https:\/\/doi.org\/10.1016\/j.jval.2019.02.004.","journal-title":"Value Health."},{"issue":"5 Suppl 1","key":"1360_CR20","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/01.mlr.0000250483.85507.04","volume":"45","author":"BB Reeve","year":"2007","unstructured":"Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22-31. https:\/\/doi.org\/10.1097\/01.mlr.0000250483.85507.04.","journal-title":"Med Care"},{"issue":"11","key":"1360_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63(11):1179\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.011.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1360_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0272989x18776637","volume":"38","author":"B Dewitt","year":"2018","unstructured":"Dewitt B, Feeny D, Fischhoff B, Cella D, Hays RD, Hess R, et al. Estimation of a preference-based summary score for the Patient-Reported Outcomes Measurement Information System: The PROMIS(\u00ae)-Preference (PROPr) Scoring System. Med Decis Making. 2018;38(6):683\u201398. https:\/\/doi.org\/10.1177\/0272989x18776637.","journal-title":"Med Decis Making"},{"issue":"1","key":"1360_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12955-021-01854-1","volume":"19","author":"J Hanmer","year":"2021","unstructured":"Hanmer J. Measuring population health: association of self-rated health and PROMIS measures with social determinants of health in a cross-sectional survey of the US population. Health Qual Life Outcomes. 2021;19(1):221. https:\/\/doi.org\/10.1186\/s12955-021-01854-1.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"1360_CR24","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2215\/cjn.01880221","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Dewitt B, Tang E, Breitner D, Saqib M, Li D, et al. Evaluation of PROMIS preference scoring system (PROPr) in patients undergoing hemodialysis or kidney transplant. Clin J Am Soc Nephrol. 2021;16(9):1328\u201336. https:\/\/doi.org\/10.2215\/cjn.01880221.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1360_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11136-021-02911-4","volume":"31","author":"T Pan","year":"2022","unstructured":"Pan T, Mulhern B, Viney R, Norman R, Tran-Duy A, Hanmer J, Devlin N. Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review. Qual Life Res. 2022;31(1):79\u201389. https:\/\/doi.org\/10.1007\/s11136-021-02911-4.","journal-title":"Qual Life Res"},{"issue":"7","key":"1360_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jval.2023.02.002","volume":"26","author":"F Rencz","year":"2023","unstructured":"Rencz F, Brodszky V, Janssen MF. A direct comparison of the measurement properties of EQ-5D-5L, PROMIS-29+2 and PROMIS global health instruments and EQ-5D-5L and PROPr utilities in a general population sample. Value Health. 2023;26(7):1045\u201356. https:\/\/doi.org\/10.1016\/j.jval.2023.02.002.","journal-title":"Value Health."},{"issue":"8","key":"1360_CR27","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s11136-023-03364-7","volume":"32","author":"B Jenei","year":"2023","unstructured":"Jenei B, Bat\u00f3 A, Mitev AZ, Brodszky V, Rencz F. Hungarian PROMIS-29+2: psychometric properties and population reference values. Qual Life Res. 2023;32(8):2179\u201394. https:\/\/doi.org\/10.1007\/s11136-023-03364-7.","journal-title":"Qual Life Res"},{"issue":"11","key":"1360_CR28","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1007\/s11136-023-03462-6","volume":"32","author":"BJ Mulhern","year":"2023","unstructured":"Mulhern BJ, Pan T, Norman R, Tran-Duy A, Hanmer J, Viney R, Devlin NJ. Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr. Qual Life Res. 2023;32(11):3147\u201360. https:\/\/doi.org\/10.1007\/s11136-023-03462-6.","journal-title":"Qual Life Res"},{"key":"1360_CR29","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.wneu.2023.06.097","volume":"181","author":"Z Nagy","year":"2024","unstructured":"Nagy Z, Kiss N, Szigeti M, \u00c1fra J, Lekka N, Misik F, et al. Construct validity of the Hungarian Version of the Patient-Reported Outcomes Measurement Information System-29 Profile Among Patients with Low Back Pain. World Neurosurg. 2024;181:e55\u201366. https:\/\/doi.org\/10.1016\/j.wneu.2023.06.097.","journal-title":"World Neurosurg."},{"issue":"34","key":"1360_CR30","first-page":"1667","volume":"144","author":"A Szende","year":"2003","unstructured":"Szende A, N\u00e9meth R. Health-related quality of life of the Hungarian population. Orv Hetil. 2003;144(34):1667\u201374.","journal-title":"Orv Hetil"},{"issue":"1","key":"1360_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11136-023-03514-x","volume":"33","author":"A Nikl","year":"2024","unstructured":"Nikl A, Janssen MF, Brodszky V, Rencz F. Hungarian population norms for the 15D generic preference-accompanied health status measure. Qual Life Res. 2024;33(1):87\u201399. https:\/\/doi.org\/10.1007\/s11136-023-03514-x.","journal-title":"Qual Life Res"},{"issue":"1","key":"1360_CR32","first-page":"4","volume":"80","author":"\u00c1 Czimbalmos","year":"1999","unstructured":"Czimbalmos \u00c1, Nagy Z, Varga Z, Husztik P. P\u00e1ciens megel\u00e9gedetts\u00e9gi vizsg\u00e1lat SF-36 k\u00e9rd\u0151\u00edvvel, a magyarorsz\u00e1gi norm\u00e1l\u00e9rt\u00e9kek meghat\u00e1roz\u00e1sa. Nepegeszseguegy. 1999;80(1):4\u201319.","journal-title":"Nepegeszseguegy"},{"key":"1360_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-023-01610-w","author":"A Bat\u00f3","year":"2023","unstructured":"Bat\u00f3 A, Brodszky V, Mitev AZ, Jenei B, Rencz F. Psychometric properties and general population reference values for PROMIS Global Health in Hungary. Eur J Health Econ. 2023. https:\/\/doi.org\/10.1007\/s10198-023-01610-w.","journal-title":"Eur J Health Econ"},{"key":"1360_CR34","unstructured":"EuroQol Group. EQ-5D-5L population norm studies. https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/population-norms\/. Accessed 17 Aug 2023."},{"issue":"3","key":"1360_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11136-015-1108-2","volume":"25","author":"T Shiroiwa","year":"2016","unstructured":"Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707\u201319. https:\/\/doi.org\/10.1007\/s11136-015-1108-2.","journal-title":"Qual Life Res"},{"issue":"4","key":"1360_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40258-022-00715-2","volume":"20","author":"S Xie","year":"2022","unstructured":"Xie S, Wu J, Xie F. Population norms for SF-6Dv2 and EQ-5D-5L in China. Appl Health Econ Health Policy. 2022;20(4):573\u201385. https:\/\/doi.org\/10.1007\/s40258-022-00715-2.","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"1360_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12955-023-02144-8","volume":"21","author":"E Olariu","year":"2023","unstructured":"Olariu E, Caplescu R, Vale L, Niculescu-Aron IG, Oluboyede Y, Paveliu MS. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania. Health Qual Life Outcomes. 2023;21(1):80. https:\/\/doi.org\/10.1186\/s12955-023-02144-8.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"1360_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11136-008-9429-z","volume":"18","author":"A Szende","year":"2009","unstructured":"Szende A, Leidy NK, St\u00e5hl E, Svensson K. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res. 2009;18(2):267\u201372. https:\/\/doi.org\/10.1007\/s11136-008-9429-z.","journal-title":"Qual Life Res"},{"issue":"12","key":"1360_CR39","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s11136-017-1699-x","volume":"26","author":"AK Po\u00f3r","year":"2017","unstructured":"Po\u00f3r AK, Rencz F, Brodszky V, Gul\u00e1csi L, Beretzky Z, Hidv\u00e9gi B, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual Life Res. 2017;26(12):3409\u201319. https:\/\/doi.org\/10.1007\/s11136-017-1699-x.","journal-title":"Qual Life Res"},{"issue":"1","key":"1360_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11136-018-2003-4","volume":"28","author":"F Rencz","year":"2019","unstructured":"Rencz F, Lakatos PL, Gul\u00e1csi L, Brodszky V, K\u00fcrti Z, Lovas S, et al. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn\u2019s disease. Qual Life Res. 2019;28(1):141\u201352. https:\/\/doi.org\/10.1007\/s11136-018-2003-4.","journal-title":"Qual Life Res"},{"issue":"4","key":"1360_CR41","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/bjd.16883","volume":"180","author":"B Tam\u00e1si","year":"2019","unstructured":"Tam\u00e1si B, Brodszky V, P\u00e9ntek M, Gul\u00e1csi L, Hajdu K, S\u00e1rdy M, et al. Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol. 2019;180(4):802\u20139. https:\/\/doi.org\/10.1111\/bjd.16883.","journal-title":"Br J Dermatol"},{"issue":"11","key":"1360_CR42","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1111\/jdv.16642","volume":"34","author":"LH Gergely","year":"2020","unstructured":"Gergely LH, G\u00e1sp\u00e1r K, Brodszky V, Kiny\u00f3 \u00c1, Szegedi A, Remenyik \u00c9, et al. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34(11):2584\u201392. https:\/\/doi.org\/10.1111\/jdv.16642.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1360_CR43","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11136-020-02732-x","volume":"30","author":"A Bat\u00f3","year":"2021","unstructured":"Bat\u00f3 A, Brodszky V, Gergely LH, G\u00e1sp\u00e1r K, Wikonk\u00e1l N, Kiny\u00f3 \u00c1, et al. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa. Qual Life Res. 2021;30(5):1477\u201390. https:\/\/doi.org\/10.1007\/s11136-020-02732-x.","journal-title":"Qual Life Res"},{"issue":"10","key":"1360_CR44","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s11136-022-03141-y","volume":"31","author":"F Rencz","year":"2022","unstructured":"Rencz F, Mukuria C, Bat\u00f3 A, Po\u00f3r AK, Finch AP. A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis. Qual Life Res. 2022;31(10):3049\u201360. https:\/\/doi.org\/10.1007\/s11136-022-03141-y.","journal-title":"Qual Life Res"},{"issue":"6s","key":"1360_CR45","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1097\/der.0000000000000908","volume":"33","author":"K Koszor\u00fa","year":"2022","unstructured":"Koszor\u00fa K, Hajdu K, Brodszky V, Szab\u00f3 \u00c1, Borza J, Bodai K, et al. General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 pandemic. Dermatitis. 2022;33(6s):S92-s103. https:\/\/doi.org\/10.1097\/der.0000000000000908.","journal-title":"Dermatitis"},{"issue":"1","key":"1360_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10198-022-01460-y","volume":"24","author":"K Koszor\u00fa","year":"2023","unstructured":"Koszor\u00fa K, Hajdu K, Brodszky V, Bat\u00f3 A, Gergely LH, Kov\u00e1cs A, et al. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. Eur J Health Econ. 2023;24(1):139\u201352. https:\/\/doi.org\/10.1007\/s10198-022-01460-y.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1360_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12955-023-02096-z","volume":"21","author":"A Nikl","year":"2023","unstructured":"Nikl A, Janssen MF, Brodszky V, Rencz F. A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample. Health Qual Life Outcomes. 2023;21(1):17. https:\/\/doi.org\/10.1186\/s12955-023-02096-z.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"1360_CR48","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.jval.2022.06.012","volume":"25","author":"F Rencz","year":"2022","unstructured":"Rencz F, Janssen MF. Analyzing the pain\/discomfort and anxiety\/depression composite domains and the meaning of discomfort in the EQ-5D: a mixed-methods study. Value Health. 2022;25(12):2003\u201316. https:\/\/doi.org\/10.1016\/j.jval.2022.06.012.","journal-title":"Value Health."},{"key":"1360_CR49","unstructured":"Hungarian Central Statistical Office. Microcensus 2016. https:\/\/www.ksh.hu\/docs\/eng\/xftp\/idoszaki\/microcensus2016\/microcensus_2016_3.pdf. Accessed 6 Oct 2022."},{"key":"1360_CR50","unstructured":"Hungarian Central Statistical Office. Tehet\u00fcnk az eg\u00e9szs\u00e9g\u00fcnk\u00e9rt \u2013 ELEF2019 gyorsjelent\u00e9s. https:\/\/www.ksh.hu\/docs\/hun\/xftp\/idoszaki\/elef\/te_2019\/index.html. Accessed 6 Oct 2022."},{"issue":"9","key":"1360_CR51","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jval.2020.03.019","volume":"23","author":"F Rencz","year":"2020","unstructured":"Rencz F, Brodszky V, Gul\u00e1csi L, Golicki D, Ruzsa G, Pickard AS, et al. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary. Value Health. 2020;23(9):1235\u201345. https:\/\/doi.org\/10.1016\/j.jval.2020.03.019.","journal-title":"Value Health."},{"issue":"7","key":"1360_CR52","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","volume":"27","author":"RD Hays","year":"2018","unstructured":"Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS(\u00ae)-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018;27(7):1885\u201391. https:\/\/doi.org\/10.1007\/s11136-018-1842-3.","journal-title":"Qual Life Res"},{"key":"1360_CR53","doi-asserted-by":"crossref","unstructured":"Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Dordrecht (NL): Springer; 2014.","DOI":"10.1007\/978-94-007-7596-1"},{"key":"1360_CR54","unstructured":"World Health Organization. WHO guidelines on physical activity and sedentary behaviour. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/337001\/9789240014886-eng.pdf. Accessed 15 Aug 2023."},{"issue":"1","key":"1360_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"key":"1360_CR56","unstructured":"World Health Organization. A healthy lifestyle \u2013 WHO recommendations. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations. Accessed 25 Aug 2023."},{"key":"1360_CR57","doi-asserted-by":"crossref","unstructured":"Devlin N, Parkin D, Janssen B. Analysis of EQ-5D Profiles. Methods for analysing and reporting EQ-5D data: Springer; 2020. p. 23\u201349.","DOI":"10.1007\/978-3-030-47622-9_2"},{"issue":"8","key":"1360_CR58","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10198-020-01225-5","volume":"21","author":"M Encheva","year":"2020","unstructured":"Encheva M, Djambazov S, Vekov T, Golicki D. EQ-5D-5L Bulgarian population norms. Eur J Health Econ. 2020;21(8):1169\u201378. https:\/\/doi.org\/10.1007\/s10198-020-01225-5.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1360_CR59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/aoms.2015.52126","volume":"13","author":"D Golicki","year":"2017","unstructured":"Golicki D, Niewada M. EQ-5D-5L Polish population norms. Arch Med Sci. 2017;13(1):191\u2013200. https:\/\/doi.org\/10.5114\/aoms.2015.52126.","journal-title":"Arch Med Sci"},{"issue":"1","key":"1360_CR60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12955-020-01584-w","volume":"18","author":"V Prevolnik Rupel","year":"2020","unstructured":"Prevolnik Rupel V, Ogorevc M. EQ-5D-5L Slovenian population norms. Health Qual Life Outcomes. 2020;18(1):333. https:\/\/doi.org\/10.1186\/s12955-020-01584-w.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"1360_CR61","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/MLR.0b013e31814848f1","volume":"45","author":"DG Fryback","year":"2007","unstructured":"Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care. 2007;45(12):1162\u201370. https:\/\/doi.org\/10.1097\/MLR.0b013e31814848f1.","journal-title":"Med Care"},{"issue":"12","key":"1360_CR62","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/hec.1823","volume":"21","author":"B van den Berg","year":"2012","unstructured":"van den Berg B. SF-6D population norms. Health Econ. 2012;21(12):1508\u201312. https:\/\/doi.org\/10.1002\/hec.1823.","journal-title":"Health Econ"},{"issue":"1","key":"1360_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/1753-6405.12005","volume":"37","author":"R Norman","year":"2013","unstructured":"Norman R, Church J, van den Berg B, Goodall S. Australian health-related quality of life population norms derived from the SF-6D. Aust N Z J Public Health. 2013;37(1):17\u201323. https:\/\/doi.org\/10.1111\/1753-6405.12005.","journal-title":"Aust N Z J Public Health"},{"issue":"3","key":"1360_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10198-014-0568-6","volume":"16","author":"PL Ferreira","year":"2015","unstructured":"Ferreira PL, Ferreira LN, Pereira LN. SF-6D Portuguese population norms. Eur J Health Econ. 2015;16(3):235\u201341. https:\/\/doi.org\/10.1007\/s10198-014-0568-6.","journal-title":"Eur J Health Econ"},{"issue":"10","key":"1360_CR65","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s11136-015-0991-x","volume":"24","author":"RM Ciconelli","year":"2015","unstructured":"Ciconelli RM, Ferraz MB, Kowalski S, Pinheiro Gda R, Sato EI. Brazilian urban population norms derived from the health-related quality of life SF-6D. Qual Life Res. 2015;24(10):2559\u201364. https:\/\/doi.org\/10.1007\/s11136-015-0991-x.","journal-title":"Qual Life Res"},{"issue":"5","key":"1360_CR66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10198-017-0912-8","volume":"19","author":"MA Garcia-Gordillo","year":"2018","unstructured":"Garcia-Gordillo MA, Collado-Mateo D, Olivares PR, Adsuar JC. Chilean population norms derived from the health-related quality of life SF-6D. Eur J Health Econ. 2018;19(5):675\u201386. https:\/\/doi.org\/10.1007\/s10198-017-0912-8.","journal-title":"Eur J Health Econ"},{"issue":"9","key":"1360_CR67","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s11136-018-1887-3","volume":"27","author":"CKH Wong","year":"2018","unstructured":"Wong CKH, Mulhern B, Cheng GHL, Lam CLK. SF-6D population norms for the Hong Kong Chinese general population. Qual Life Res. 2018;27(9):2349\u201359. https:\/\/doi.org\/10.1007\/s11136-018-1887-3.","journal-title":"Qual Life Res"},{"issue":"3","key":"1360_CR68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40273-021-01109-3","volume":"40","author":"T Pan","year":"2022","unstructured":"Pan T, Mulhern B, Viney R, Norman R, Hanmer J, Devlin N. A comparison of PROPr and EQ-5D-5L value sets. Pharmacoeconomics. 2022;40(3):297\u2013307. https:\/\/doi.org\/10.1007\/s40273-021-01109-3.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1360_CR69","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/0272989x19841587","volume":"39","author":"B Roudijk","year":"2019","unstructured":"Roudijk B, Donders ART, Stalmeier PFM. Cultural values: can they explain differences in health utilities between countries? Med Decis Making. 2019;39(5):605\u201316. https:\/\/doi.org\/10.1177\/0272989x19841587.","journal-title":"Med Decis Making"},{"issue":"3","key":"1360_CR70","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40271-022-00611-w","volume":"16","author":"T Peasgood","year":"2023","unstructured":"Peasgood T, Caruana JM, Mukuria C. Systematic review of the effect of a one-day versus seven-day recall duration on patient reported outcome measures (PROMs). Patient. 2023;16(3):201\u201321. https:\/\/doi.org\/10.1007\/s40271-022-00611-w.","journal-title":"Patient"},{"issue":"4","key":"1360_CR71","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1185\/03007990902774765","volume":"25","author":"DE Stull","year":"2009","unstructured":"Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin. 2009;25(4):929\u201342. https:\/\/doi.org\/10.1185\/03007990902774765.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"1360_CR72","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11136-011-0003-8","volume":"21","author":"JM Norquist","year":"2012","unstructured":"Norquist JM, Girman C, Fehnel S, DeMuro-Mercon C, Santanello N. Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration. Qual Life Res. 2012;21(6):1013\u201320. https:\/\/doi.org\/10.1007\/s11136-011-0003-8.","journal-title":"Qual Life Res"},{"issue":"1","key":"1360_CR73","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pain.2008.03.024","volume":"139","author":"JE Broderick","year":"2008","unstructured":"Broderick JE, Schwartz JE, Vikingstad G, Pribbernow M, Grossman S, Stone AA. The accuracy of pain and fatigue items across different reporting periods. Pain. 2008;139(1):146\u201357. https:\/\/doi.org\/10.1016\/j.pain.2008.03.024.","journal-title":"Pain"},{"issue":"11","key":"1360_CR74","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032859","volume":"9","author":"J Topp","year":"2019","unstructured":"Topp J, Andrees V, Heesen C, Augustin M, Blome C. Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany. BMJ Open. 2019;9(11): e032859. https:\/\/doi.org\/10.1136\/bmjopen-2019-032859.","journal-title":"BMJ Open"},{"issue":"1","key":"1360_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-021-00406-x","volume":"6","author":"I Spronk","year":"2022","unstructured":"Spronk I, Polinder S, Bonsel GJ, Janssen MF, Haagsma JA. Adding a fatigue item to the EQ-5D-5L improves its psychometric performance in the general population. J Patient Rep Outcomes. 2022;6(1):1. https:\/\/doi.org\/10.1186\/s41687-021-00406-x.","journal-title":"J Patient Rep Outcomes."},{"issue":"5","key":"1360_CR76","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1524-4733.2010.00727.x","volume":"13","author":"TV Perneger","year":"2010","unstructured":"Perneger TV, Combescure C, Courvoisier DS. General population reference values for the French version of the EuroQol EQ-5D health utility instrument. Value Health. 2010;13(5):631\u20135. https:\/\/doi.org\/10.1111\/j.1524-4733.2010.00727.x.","journal-title":"Value Health."},{"issue":"6","key":"1360_CR77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3961\/jpmph.16.076","volume":"50","author":"SH Kim","year":"2017","unstructured":"Kim SH, Jo MW, Ock M, Lee SI. Exploratory study of dimensions of health-related quality of life in the general population of South Korea. J Prev Med Public Health. 2017;50(6):361\u20138. https:\/\/doi.org\/10.3961\/jpmph.16.076.","journal-title":"J Prev Med Public Health"},{"issue":"1","key":"1360_CR78","first-page":"8","volume":"3","author":"C Lim","year":"2017","unstructured":"Lim C, Shafie A, Thakumar A. Exploration of EQ-5D-5L bolt-on items among Malaysian population. Malaysian J Pharm. 2017;3(1):8\u201317.","journal-title":"Malaysian J Pharm."},{"key":"1360_CR79","doi-asserted-by":"crossref","unstructured":"Devlin N, Roudijk B, Ludwig K. Value sets for EQ-5D-5L: Springer Cham; 2022.","DOI":"10.1007\/978-3-030-89289-0"},{"issue":"1","key":"1360_CR80","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41927-022-00245-3","volume":"6","author":"CP Klapproth","year":"2022","unstructured":"Klapproth CP, Fischer F, Merbach M, Rose M, Obbarius A. Psychometric properties of the PROMIS preference score (PROPr) in patients with rheumatological and psychosomatic conditions. BMC Rheumatol. 2022;6(1):15. https:\/\/doi.org\/10.1186\/s41927-022-00245-3.","journal-title":"BMC Rheumatol."},{"issue":"6","key":"1360_CR81","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/mlr.0000000000001325","volume":"58","author":"JE Brazier","year":"2020","unstructured":"Brazier JE, Mulhern BJ, Bjorner JB, Gandek B, Rowen D, Alonso J, et al. Developing a new version of the SF-6D Health State Classification System from the SF-36v2: SF-6Dv2. Med Care. 2020;58(6):557\u201365. https:\/\/doi.org\/10.1097\/mlr.0000000000001325.","journal-title":"Med Care"},{"issue":"6","key":"1360_CR82","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/mlr.0000000000001324","volume":"58","author":"BJ Mulhern","year":"2020","unstructured":"Mulhern BJ, Bansback N, Norman R, Brazier J. Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Med Care. 2020;58(6):566\u201373. https:\/\/doi.org\/10.1097\/mlr.0000000000001324.","journal-title":"Med Care"},{"issue":"8","key":"1360_CR83","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s11136-017-1559-8","volume":"26","author":"FA Sayah","year":"2017","unstructured":"Sayah FA, Qiu W, Xie F, Johnson JA. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Qual Life Res. 2017;26(8):2057\u201366. https:\/\/doi.org\/10.1007\/s11136-017-1559-8.","journal-title":"Qual Life Res"},{"issue":"8","key":"1360_CR84","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/0272989x17706355","volume":"37","author":"A Bhadhuri","year":"2017","unstructured":"Bhadhuri A, Jowett S, Jolly K, Al-Janabi H. A comparison of the validity and responsiveness of the EQ-5D-5L and SF-6D for measuring health spillovers: a study of the family impact of meningitis. Med Decis Making. 2017;37(8):882\u201393. https:\/\/doi.org\/10.1177\/0272989x17706355.","journal-title":"Med Decis Making"},{"issue":"9","key":"1360_CR85","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10198-014-0664-7","volume":"16","author":"F Yang","year":"2015","unstructured":"Yang F, Lau T, Lee E, Vathsala A, Chia KS, Luo N. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). Eur J Health Econ. 2015;16(9):1019\u201326. https:\/\/doi.org\/10.1007\/s10198-014-0664-7.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1360_CR86","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/13696998.2022.2087409","volume":"25","author":"N Li","year":"2022","unstructured":"Li N, Boonen A, van den Bergh JP, van Kuijk SMJ, Wyers CE, van Oostwaard M, et al. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a fracture liaison service. J Med Econ. 2022;25(1):829\u201339. https:\/\/doi.org\/10.1080\/13696998.2022.2087409.","journal-title":"J Med Econ"},{"issue":"2","key":"1360_CR87","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40273-019-00854-w","volume":"38","author":"X Qian","year":"2020","unstructured":"Qian X, Tan RL, Chuang LH, Luo N. Measurement properties of commonly used generic preference-based measures in East and South-East Asia: a systematic review. Pharmacoeconomics. 2020;38(2):159\u201370. https:\/\/doi.org\/10.1007\/s40273-019-00854-w.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1360_CR88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12955-021-01762-4","volume":"19","author":"AN Lamu","year":"2021","unstructured":"Lamu AN, Bj\u00f6rkman L, Hamre HJ, Alr\u00e6k T, Musial F, Robberstad B. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. Health Qual Life Outcomes. 2021;19(1):125. https:\/\/doi.org\/10.1186\/s12955-021-01762-4.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1360_CR89","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10198-021-01273-5","volume":"22","author":"RH Xu","year":"2021","unstructured":"Xu RH, Dong D, Luo N, Wong EL, Wu Y, Yu S, et al. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia. Eur J Health Econ. 2021;22(4):547\u201357. https:\/\/doi.org\/10.1007\/s10198-021-01273-5.","journal-title":"Eur J Health Econ"},{"issue":"2","key":"1360_CR90","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1751-5823.2010.00112.x","volume":"78","author":"J Bethlehem","year":"2010","unstructured":"Bethlehem J. Selection bias in web surveys. Int Stat Rev. 2010;78(2):161\u201388.","journal-title":"Int Stat Rev"},{"issue":"1","key":"1360_CR91","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12874-020-01138-0","volume":"20","author":"S Kelfve","year":"2020","unstructured":"Kelfve S, Kivi M, Johansson B, Lindwall M. Going web or staying paper? The use of web-surveys among older people. BMC Med Res Methodol. 2020;20(1):252. https:\/\/doi.org\/10.1186\/s12874-020-01138-0.","journal-title":"BMC Med Res Methodol"},{"key":"1360_CR92","unstructured":"Eurostat. Individuals\u2014internet use. https:\/\/ec.europa.eu\/eurostat\/databrowser\/bookmark\/2983627a-a0f1-40a6-af69-cdba9ccd6dfa?lang=en. Accessed 4 Aug 2023."},{"key":"1360_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.vhri.2020.07.573","volume":"22","author":"F Rencz","year":"2020","unstructured":"Rencz F, Tam\u00e1si B, Brodszky V, Ruzsa G, Gul\u00e1csi L, P\u00e9ntek M. Did you get what you wanted? Patient satisfaction and congruence between preferred and perceived roles in medical decision making in a Hungarian national survey. Value Health Reg Issues. 2020;22:61\u20137. https:\/\/doi.org\/10.1016\/j.vhri.2020.07.573.","journal-title":"Value Health Reg Issues."},{"issue":"1","key":"1360_CR94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/135581969600100105","volume":"1","author":"MJ Barry","year":"1996","unstructured":"Barry MJ, Walker-Corkery E, Chang Y, Tyll LT, Cherkin DC, Fowler FJ. Measurement of overall and disease-specific health status: does the order of questionnaires make a difference? J Health Serv Res Policy. 1996;1(1):20\u20137. https:\/\/doi.org\/10.1177\/135581969600100105.","journal-title":"J Health Serv Res Policy"},{"issue":"7","key":"1360_CR95","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1023\/b:Qure.0000037499.80080.07","volume":"13","author":"YB Cheung","year":"2004","unstructured":"Cheung YB, Wong LC, Tay MH, Toh CK, Koo WH, Epstein R, Goh C. Order effects in the assessment of quality of life in cancer patients. Qual Life Res. 2004;13(7):1217\u201323. https:\/\/doi.org\/10.1023\/b:Qure.0000037499.80080.07.","journal-title":"Qual Life Res"},{"issue":"2","key":"1360_CR96","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11136-004-0727-9","volume":"14","author":"AL Childs","year":"2005","unstructured":"Childs AL. Effect of order of administration of health-related quality of life interview instruments on responses. Qual Life Res. 2005;14(2):493\u2013500. https:\/\/doi.org\/10.1007\/s11136-004-0727-9.","journal-title":"Qual Life Res"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-024-01360-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-024-01360-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-024-01360-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T05:10:44Z","timestamp":1713849044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-024-01360-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s40273-024-01360-4","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"30 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the study conception and design and interpretation of data. The first draft of the manuscript was written by A.N. and F.R. The manuscript was critically revised by all authors. F.R. conducted data collection. A.N., B.J. and F.R. analysed the data. A.N. and F.R. obtained funding for the research. All authors read and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Open access funding provided by Corvinus University of Budapest. Data collection was supported by the Hungarian Academy of Sciences (MTA-PPD 462025). Anna Nikl\u2019s work was supported by the \u00daNKP-23-3 New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund (\u00daNKP-23-3-II-SE-17). Fanni Rencz\u2019s work was supported by the J\u00e1nos Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO\/00304\/21) and the New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund in Hungary (\u00daNKP-23-5-CORVINUS-5).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"M.F.J. and F.R. are active members of the EuroQol Group. The views expressed in this article are those of the authors and do not necessarily reflect those of the EuroQol Research Foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data of this study are available from the corresponding author upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The code used for the statistical analysis is available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval was obtained from the Research Ethics Committee of the Corvinus University of Budapest (no. KRH\/343\/2020).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}